APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Digital Chronic Disease Management

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digital Chronic Disease Management Market Outlook and Growth Opportunities 2026

Report ID 17411594042 May 2026192 pages

Choose your research edition.

Industry ResearchDigital Chronic Disease Management Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Chronic Disease Management Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Digital Chronic Disease Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Chronic Disease Management Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Chronic Disease Management Market Analysis and Forecast 2026-2032254 pages · $4,950 USD

Market perspective

The global Digital Chronic Disease Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digital Chronic Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digital Chronic Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Chronic Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digital Chronic Disease Management market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digital Chronic Disease Management market include S3 Connected Health, WellDoc, AstraZeneca, NTT DATA, Credo Health Services, Dawn Health, Bayer, Medtronic and Teladoc Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digital Chronic Disease Management market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digital Chronic Disease Management and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digital Chronic Disease Management revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital Chronic Disease Management market.

Digital Chronic Disease Management Segment by Company

S3 Connected Health

WellDoc

AstraZeneca

NTT DATA

Credo Health Services

Dawn Health

Bayer

Medtronic

Teladoc Health

ScienceSoft

TriZetto Healthcare (Cognizant)

Omada Health

Phable

Pack Health

Epic Systems

Pathmate

EveryDose

Aptar Digital Health

VITech

ClouDr Group

JD Health

Ali Health

Ping An Good Doctor

We Doctor Group

Wei Mai

Medlinker

Digital Chronic Disease Management Segment by Type

Charge

Free

Digital Chronic Disease Management Segment by Application

Medical Institutions

Pharmacy

Chronic Disease Patients

Digital Chronic Disease Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Digital Chronic Disease Management status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digital Chronic Disease Management key companies, revenue, market share, and recent developments.

3. To split the Digital Chronic Disease Management breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digital Chronic Disease Management market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digital Chronic Disease Management significant trends, drivers, influence factors in global and regions.

6. To analyze Digital Chronic Disease Management competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Chronic Disease Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Chronic Disease Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Chronic Disease Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Chronic Disease Management industry.

Chapter 3: Detailed analysis of Digital Chronic Disease Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digital Chronic Disease Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digital Chronic Disease Management in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digital Chronic Disease Management Industry Trends Table 2. Digital Chronic Disease Management Industry Drivers Table 3. Digital Chronic Disease Management Industry Opportunities and Challenges Table 4. Digital Chronic Disease Management Industry Restraints Table 5. Global Digital Chronic Disease Management Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digital Chronic Disease Management Revenue Share by Company (2021-2026) Table 7. Global Digital Chronic Disease Management Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digital Chronic Disease Management Key Company Manufacturing Base & Headquarters Table 9. Global Digital Chronic Disease Management Company, Product Type & Application Table 10. Global Digital Chronic Disease Management Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digital Chronic Disease Management by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Charge Table 15. Significant Companies of Free Table 16. Global Digital Chronic Disease Management Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Digital Chronic Disease Management Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Digital Chronic Disease Management Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Digital Chronic Disease Management Sales Value Share by Type (2021-2026) Table 20. Global Digital Chronic Disease Management Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Institutions Table 22. Significant Companies of Pharmacy Table 23. Significant Companies of Chronic Disease Patients Table 24. Global Digital Chronic Disease Management Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Digital Chronic Disease Management Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Digital Chronic Disease Management Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Digital Chronic Disease Management Sales Value Share by Application (2021-2026) Table 28. Global Digital Chronic Disease Management Sales Value Share by Application (2027-2032) Table 29. Global Digital Chronic Disease Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Digital Chronic Disease Management Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Digital Chronic Disease Management Sales Value Share by Region (2021-2026) Table 32. Global Digital Chronic Disease Management Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Digital Chronic Disease Management Sales Value Share by Region (2027-2032) Table 34. Global Digital Chronic Disease Management Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Digital Chronic Disease Management Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Digital Chronic Disease Management Sales Value Market Share by Country (2021-2026) Table 37. Global Digital Chronic Disease Management Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Digital Chronic Disease Management Sales Value Market Share by Country (2027-2032) Table 39. S3 Connected Health Company Information Table 40. S3 Connected Health Business Overview Table 41. S3 Connected Health Digital Chronic Disease Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. S3 Connected Health Digital Chronic Disease Management Product Portfolio Table 43. S3 Connected Health Recent Development Table 44. WellDoc Company Information Table 45. WellDoc Business Overview Table 46. WellDoc Digital Chronic Disease Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. WellDoc Digital Chronic Disease Management Product Portfolio Table 48. WellDoc Recent Development Table 49. AstraZeneca Company Information Table 50. AstraZeneca Business Overview Table 51. AstraZeneca Digital Chronic Disease Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. AstraZeneca Digital Chronic Disease Management Product Portfolio Table 53. AstraZeneca Recent Development Table 54. NTT DATA Company Information Table 55. NTT DATA Business Overview Table 56. NTT DATA Digital Chronic Disease Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. NTT DATA Digital Chronic Disease Management Product Portfolio Table 58. NTT DATA Recent Development Table 59. Credo Health Services Company Information Table 60. Credo Health Services Business Overview Table 61. Credo Health Services Digital Chronic Disease Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Credo Health Services Digital Chronic Disease Management Product Portfolio Table 63. Credo Health Services Recent Development Table 64. Dawn Health Company Information Table 65. Dawn Health Business Overview Table 66. Dawn Health Digital Chronic Disease Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Dawn Health Digital Chronic Disease Management Product Portfolio Table 68. Dawn Health Recent Development Table 69. Bayer Company Information Table 70. Bayer Business Overview Table 71. Bayer Digital Chronic Disease Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bayer Digital Chronic Disease Management Product Portfolio Table 73. Bayer Recent Development Table 74. Medtronic Company Information Table 75. Medtronic Business Overview Table 76. Medtronic Digital Chronic Disease Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Medtronic Digital Chronic Disease Management Product Portfolio Table 78. Medtronic Recent Development Table 79. Teladoc Health Company Information Table 80. Teladoc Health Business Overview Table 81. Teladoc Health Digital Chronic Disease Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Teladoc Health Digital Chronic Disease Management Product Portfolio Table 83. Teladoc Health Recent Development Table 84. ScienceSoft Company Information Table 85. ScienceSoft Business Overview Table 86. ScienceSoft Digital Chronic Disease Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. ScienceSoft Digital Chronic Disease Management Product Portfolio Table 88. ScienceSoft Recent Development Table 89. TriZetto Healthcare (Cognizant) Company Information Table 90. TriZetto Healthcare (Cognizant) Business Overview Table 91. TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Portfolio Table 93. TriZetto Healthcare (Cognizant) Recent Development Table 94. Omada Health Company Information Table 95. Omada Health Business Overview Table 96. Omada Health Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Omada Health Digital Chronic Disease Management Product Portfolio Table 98. Omada Health Recent Development Table 99. Phable Company Information Table 100. Phable Business Overview Table 101. Phable Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Phable Digital Chronic Disease Management Product Portfolio Table 103. Phable Recent Development Table 104. Pack Health Company Information Table 105. Pack Health Business Overview Table 106. Pack Health Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Pack Health Digital Chronic Disease Management Product Portfolio Table 108. Pack Health Recent Development Table 109. Epic Systems Company Information Table 110. Epic Systems Business Overview Table 111. Epic Systems Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Epic Systems Digital Chronic Disease Management Product Portfolio Table 113. Epic Systems Recent Development Table 114. Pathmate Company Information Table 115. Pathmate Business Overview Table 116. Pathmate Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Pathmate Digital Chronic Disease Management Product Portfolio Table 118. Pathmate Recent Development Table 119. EveryDose Company Information Table 120. EveryDose Business Overview Table 121. EveryDose Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. EveryDose Digital Chronic Disease Management Product Portfolio Table 123. EveryDose Recent Development Table 124. Aptar Digital Health Company Information Table 125. Aptar Digital Health Business Overview Table 126. Aptar Digital Health Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Aptar Digital Health Digital Chronic Disease Management Product Portfolio Table 128. Aptar Digital Health Recent Development Table 129. VITech Company Information Table 130. VITech Business Overview Table 131. VITech Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. VITech Digital Chronic Disease Management Product Portfolio Table 133. VITech Recent Development Table 134. ClouDr Group Company Information Table 135. ClouDr Group Business Overview Table 136. ClouDr Group Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. ClouDr Group Digital Chronic Disease Management Product Portfolio Table 138. ClouDr Group Recent Development Table 139. JD Health Company Information Table 140. JD Health Business Overview Table 141. JD Health Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. JD Health Digital Chronic Disease Management Product Portfolio Table 143. JD Health Recent Development Table 144. Ali Health Company Information Table 145. Ali Health Business Overview Table 146. Ali Health Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Ali Health Digital Chronic Disease Management Product Portfolio Table 148. Ali Health Recent Development Table 149. Ping An Good Doctor Company Information Table 150. Ping An Good Doctor Business Overview Table 151. Ping An Good Doctor Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Ping An Good Doctor Digital Chronic Disease Management Product Portfolio Table 153. Ping An Good Doctor Recent Development Table 154. We Doctor Group Company Information Table 155. We Doctor Group Business Overview Table 156. We Doctor Group Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. We Doctor Group Digital Chronic Disease Management Product Portfolio Table 158. We Doctor Group Recent Development Table 159. Wei Mai Company Information Table 160. Wei Mai Business Overview Table 161. Wei Mai Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. Wei Mai Digital Chronic Disease Management Product Portfolio Table 163. Wei Mai Recent Development Table 164. Medlinker Company Information Table 165. Medlinker Business Overview Table 166. Medlinker Digital Chronic Disease Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. Medlinker Digital Chronic Disease Management Product Portfolio Table 168. Medlinker Recent Development Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Digital Chronic Disease Management Product Image Figure 2. Global Digital Chronic Disease Management Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million) Figure 4. Global Digital Chronic Disease Management Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Charge Image Figure 8. Free Image Figure 9. Global Digital Chronic Disease Management Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Digital Chronic Disease Management Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Digital Chronic Disease Management Sales Value Share by Type (2021-2032) Figure 12. Medical Institutions Image Figure 13. Pharmacy Image Figure 14. Chronic Disease Patients Image Figure 15. Global Digital Chronic Disease Management Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Digital Chronic Disease Management Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Digital Chronic Disease Management Sales Value Share by Application (2021-2032) Figure 18. Global Digital Chronic Disease Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Digital Chronic Disease Management Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Digital Chronic Disease Management Sales Value (2021-2032) & (US$ Million) Figure 21. North America Digital Chronic Disease Management Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Digital Chronic Disease Management Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Digital Chronic Disease Management Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Digital Chronic Disease Management Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Digital Chronic Disease Management Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Digital Chronic Disease Management Sales Value (2021-2032) & (US$ Million) Figure 27. South America Digital Chronic Disease Management Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Digital Chronic Disease Management Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Digital Chronic Disease Management Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Digital Chronic Disease Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Charge
  • Free
Applications
  • Medical Institutions
  • Pharmacy
  • Chronic Disease Patients
Companies covered
  • S3 Connected Health
  • WellDoc
  • AstraZeneca
  • NTT DATA
  • Credo Health Services
  • Dawn Health
  • Bayer
  • Medtronic
  • Teladoc Health
  • ScienceSoft
  • TriZetto Healthcare (Cognizant)
  • Omada Health
  • Phable
  • Pack Health
  • Epic Systems
  • Pathmate
  • EveryDose
  • Aptar Digital Health
  • VITech
  • ClouDr Group
  • JD Health
  • Ali Health
  • Ping An Good Doctor
  • We Doctor Group
  • Wei Mai
  • Medlinker

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digital Chronic Disease Management Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digital Chronic Disease Management Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digital Chronic Disease Management Market Dynamics
  1. 2.1 Digital Chronic Disease Management Industry Trends
  2. 2.2 Digital Chronic Disease Management Industry Drivers
  3. 2.3 Digital Chronic Disease Management Industry Opportunities and Challenges
  4. 2.4 Digital Chronic Disease Management Industry Restraints
3 Digital Chronic Disease Management Market by Company
  1. 3.1 Global Digital Chronic Disease Management Company Revenue Ranking in 2025
  2. 3.2 Global Digital Chronic Disease Management Revenue by Company (2021-2026)
  3. 3.3 Global Digital Chronic Disease Management Company Ranking (2024-2026)
  4. 3.4 Global Digital Chronic Disease Management Company Manufacturing Base and Headquarters
  5. 3.5 Global Digital Chronic Disease Management Company Product Type and Application
  6. 3.6 Global Digital Chronic Disease Management Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digital Chronic Disease Management Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digital Chronic Disease Management Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digital Chronic Disease Management Market by Type
  1. 4.1 Digital Chronic Disease Management Type Introduction
  2. 4.1.1 Charge
  3. 4.1.2 Free
  4. 4.2 Global Digital Chronic Disease Management Sales Value by Type
  5. 4.2.1 Global Digital Chronic Disease Management Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Digital Chronic Disease Management Sales Value by Type (2021-2032)
  7. 4.2.3 Global Digital Chronic Disease Management Sales Value Share by Type (2021-2032)
5 Digital Chronic Disease Management Market by Application
  1. 5.1 Digital Chronic Disease Management Application Introduction
  2. 5.1.1 Medical Institutions
  3. 5.1.2 Pharmacy
  4. 5.1.3 Chronic Disease Patients
  5. 5.2 Global Digital Chronic Disease Management Sales Value by Application
  6. 5.2.1 Global Digital Chronic Disease Management Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Digital Chronic Disease Management Sales Value by Application (2021-2032)
  8. 5.2.3 Global Digital Chronic Disease Management Sales Value Share by Application (2021-2032)
6 Digital Chronic Disease Management Regional Value Analysis
  1. 6.1 Global Digital Chronic Disease Management Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digital Chronic Disease Management Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digital Chronic Disease Management Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digital Chronic Disease Management Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digital Chronic Disease Management Sales Value (2021-2032)
  7. 6.3.2 North America Digital Chronic Disease Management Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digital Chronic Disease Management Sales Value (2021-2032)
  10. 6.4.2 Europe Digital Chronic Disease Management Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digital Chronic Disease Management Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digital Chronic Disease Management Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digital Chronic Disease Management Sales Value (2021-2032)
  16. 6.6.2 South America Digital Chronic Disease Management Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digital Chronic Disease Management Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digital Chronic Disease Management Sales Value Share by Country, 2025 VS 2032
7 Digital Chronic Disease Management Country-level Value Analysis
  1. 7.1 Global Digital Chronic Disease Management Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digital Chronic Disease Management Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digital Chronic Disease Management Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digital Chronic Disease Management Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digital Chronic Disease Management Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digital Chronic Disease Management Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digital Chronic Disease Management Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 S3 Connected Health
  2. 8.1.1 S3 Connected Health Company Information
  3. 8.1.2 S3 Connected Health Business Overview
  4. 8.1.3 S3 Connected Health Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  5. 8.1.4 S3 Connected Health Digital Chronic Disease Management Product Portfolio
  6. 8.1.5 S3 Connected Health Recent Developments
  7. 8.2 WellDoc
  8. 8.2.1 WellDoc Company Information
  9. 8.2.2 WellDoc Business Overview
  10. 8.2.3 WellDoc Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  11. 8.2.4 WellDoc Digital Chronic Disease Management Product Portfolio
  12. 8.2.5 WellDoc Recent Developments
  13. 8.3 AstraZeneca
  14. 8.3.1 AstraZeneca Company Information
  15. 8.3.2 AstraZeneca Business Overview
  16. 8.3.3 AstraZeneca Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Digital Chronic Disease Management Product Portfolio
  18. 8.3.5 AstraZeneca Recent Developments
  19. 8.4 NTT DATA
  20. 8.4.1 NTT DATA Company Information
  21. 8.4.2 NTT DATA Business Overview
  22. 8.4.3 NTT DATA Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NTT DATA Digital Chronic Disease Management Product Portfolio
  24. 8.4.5 NTT DATA Recent Developments
  25. 8.5 Credo Health Services
  26. 8.5.1 Credo Health Services Company Information
  27. 8.5.2 Credo Health Services Business Overview
  28. 8.5.3 Credo Health Services Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Credo Health Services Digital Chronic Disease Management Product Portfolio
  30. 8.5.5 Credo Health Services Recent Developments
  31. 8.6 Dawn Health
  32. 8.6.1 Dawn Health Company Information
  33. 8.6.2 Dawn Health Business Overview
  34. 8.6.3 Dawn Health Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Dawn Health Digital Chronic Disease Management Product Portfolio
  36. 8.6.5 Dawn Health Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Digital Chronic Disease Management Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 Medtronic
  44. 8.8.1 Medtronic Company Information
  45. 8.8.2 Medtronic Business Overview
  46. 8.8.3 Medtronic Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Medtronic Digital Chronic Disease Management Product Portfolio
  48. 8.8.5 Medtronic Recent Developments
  49. 8.9 Teladoc Health
  50. 8.9.1 Teladoc Health Company Information
  51. 8.9.2 Teladoc Health Business Overview
  52. 8.9.3 Teladoc Health Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teladoc Health Digital Chronic Disease Management Product Portfolio
  54. 8.9.5 Teladoc Health Recent Developments
  55. 8.10 ScienceSoft
  56. 8.10.1 ScienceSoft Company Information
  57. 8.10.2 ScienceSoft Business Overview
  58. 8.10.3 ScienceSoft Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ScienceSoft Digital Chronic Disease Management Product Portfolio
  60. 8.10.5 ScienceSoft Recent Developments
  61. 8.11 TriZetto Healthcare (Cognizant)
  62. 8.11.1 TriZetto Healthcare (Cognizant) Company Information
  63. 8.11.2 TriZetto Healthcare (Cognizant) Business Overview
  64. 8.11.3 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  65. 8.11.4 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Portfolio
  66. 8.11.5 TriZetto Healthcare (Cognizant) Recent Developments
  67. 8.12 Omada Health
  68. 8.12.1 Omada Health Company Information
  69. 8.12.2 Omada Health Business Overview
  70. 8.12.3 Omada Health Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Omada Health Digital Chronic Disease Management Product Portfolio
  72. 8.12.5 Omada Health Recent Developments
  73. 8.13 Phable
  74. 8.13.1 Phable Company Information
  75. 8.13.2 Phable Business Overview
  76. 8.13.3 Phable Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Phable Digital Chronic Disease Management Product Portfolio
  78. 8.13.5 Phable Recent Developments
  79. 8.14 Pack Health
  80. 8.14.1 Pack Health Company Information
  81. 8.14.2 Pack Health Business Overview
  82. 8.14.3 Pack Health Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Pack Health Digital Chronic Disease Management Product Portfolio
  84. 8.14.5 Pack Health Recent Developments
  85. 8.15 Epic Systems
  86. 8.15.1 Epic Systems Company Information
  87. 8.15.2 Epic Systems Business Overview
  88. 8.15.3 Epic Systems Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Epic Systems Digital Chronic Disease Management Product Portfolio
  90. 8.15.5 Epic Systems Recent Developments
  91. 8.16 Pathmate
  92. 8.16.1 Pathmate Company Information
  93. 8.16.2 Pathmate Business Overview
  94. 8.16.3 Pathmate Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Pathmate Digital Chronic Disease Management Product Portfolio
  96. 8.16.5 Pathmate Recent Developments
  97. 8.17 EveryDose
  98. 8.17.1 EveryDose Company Information
  99. 8.17.2 EveryDose Business Overview
  100. 8.17.3 EveryDose Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  101. 8.17.4 EveryDose Digital Chronic Disease Management Product Portfolio
  102. 8.17.5 EveryDose Recent Developments
  103. 8.18 Aptar Digital Health
  104. 8.18.1 Aptar Digital Health Company Information
  105. 8.18.2 Aptar Digital Health Business Overview
  106. 8.18.3 Aptar Digital Health Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Aptar Digital Health Digital Chronic Disease Management Product Portfolio
  108. 8.18.5 Aptar Digital Health Recent Developments
  109. 8.19 VITech
  110. 8.19.1 VITech Company Information
  111. 8.19.2 VITech Business Overview
  112. 8.19.3 VITech Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  113. 8.19.4 VITech Digital Chronic Disease Management Product Portfolio
  114. 8.19.5 VITech Recent Developments
  115. 8.20 ClouDr Group
  116. 8.20.1 ClouDr Group Company Information
  117. 8.20.2 ClouDr Group Business Overview
  118. 8.20.3 ClouDr Group Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  119. 8.20.4 ClouDr Group Digital Chronic Disease Management Product Portfolio
  120. 8.20.5 ClouDr Group Recent Developments
  121. 8.21 JD Health
  122. 8.21.1 JD Health Company Information
  123. 8.21.2 JD Health Business Overview
  124. 8.21.3 JD Health Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  125. 8.21.4 JD Health Digital Chronic Disease Management Product Portfolio
  126. 8.21.5 JD Health Recent Developments
  127. 8.22 Ali Health
  128. 8.22.1 Ali Health Company Information
  129. 8.22.2 Ali Health Business Overview
  130. 8.22.3 Ali Health Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Ali Health Digital Chronic Disease Management Product Portfolio
  132. 8.22.5 Ali Health Recent Developments
  133. 8.23 Ping An Good Doctor
  134. 8.23.1 Ping An Good Doctor Company Information
  135. 8.23.2 Ping An Good Doctor Business Overview
  136. 8.23.3 Ping An Good Doctor Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Ping An Good Doctor Digital Chronic Disease Management Product Portfolio
  138. 8.23.5 Ping An Good Doctor Recent Developments
  139. 8.24 We Doctor Group
  140. 8.24.1 We Doctor Group Company Information
  141. 8.24.2 We Doctor Group Business Overview
  142. 8.24.3 We Doctor Group Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  143. 8.24.4 We Doctor Group Digital Chronic Disease Management Product Portfolio
  144. 8.24.5 We Doctor Group Recent Developments
  145. 8.25 Wei Mai
  146. 8.25.1 Wei Mai Company Information
  147. 8.25.2 Wei Mai Business Overview
  148. 8.25.3 Wei Mai Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Wei Mai Digital Chronic Disease Management Product Portfolio
  150. 8.25.5 Wei Mai Recent Developments
  151. 8.26 Medlinker
  152. 8.26.1 Medlinker Company Information
  153. 8.26.2 Medlinker Business Overview
  154. 8.26.3 Medlinker Digital Chronic Disease Management Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Medlinker Digital Chronic Disease Management Product Portfolio
  156. 8.26.5 Medlinker Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst